Acquisition - September 2, 2022
Novo Nordisk acquires Forma Therapeutics
The two companies have entered into an agreement under which Novo Nordisk will acquire Forma Therapeutics for 20 USD per share in cash, which represents a total equity value of 1.1 billion USD. Forma Therapeutics is a clinical-stage biopharmaceutical company focused on transforming the lives of patients with sickle cell disease (SCD) and rare blood […]
Acquisition - August 19, 2022
iZafe to acquire Pilloxa
iZafe Group has signed a letter of intent with Pilloxa regarding the acquisition of 100 per cent of the shares in Pilloxa. Pilloxa has developed a technology platform for better compliance that pharmaceutical companies use to design digital patient support. The acquisition creates a new company in digital health that is well positioned to become […]
Acquisition - August 16, 2022
EQT makes buy-out offer for Karo Pharma
Private equity fund EQT has made a cash offer for the remaining shares in Swedish biopharmaceuticals group Karo Pharma. EQT currently owns 86% of Karo Pharma. The total value of the offer is 2.23 billion Swedish crowns ($215.15 million), valuing Karo Pharma at 16.4 billion, EQT subsidiary Karo Intressenter said in a statement. In 2018, […]
Acquisition - August 12, 2022
AstraZeneca completes acquisition of TeneoTwo
The pharma giant has completed the acquisition of TeneoTwo (announced July 5 2022), including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluation in relapsed and refractory B-cell non-Hodgkin lymphoma. AstraZeneca will develop TNB-486 as a potential new medicine for B-cell haematologic malignancies. An upfront payment of 100 million USD AstraZeneca has acquired […]
Acquisition - June 2, 2022
Senzime to acquire Respiratory Motion
Senzime has signed an agreement to acquire 100 percent of the shares in the US company Respiratory Motion, Inc. for an initial consideration of 19 million USD on a cash- and debt-free basis with an additional potential earn-out payment of up to 25 million USD, paid out earliest in 2024. The sellers consist of a […]
Acquisition - May 11, 2022
BICO acquires Allegro 3D
BICO has acquired all the shares in San Diego-based Allegro 3D for an up-front enterprise value of USD 6 million. Additionally, the shareholders can receive USD 5 million in an earnout payment contingent on Allegro 3D’s financial performance in the coming two years. The entire purchase price will be paid in cash. Allegro 3D’s patented […]
